OR WAIT null SECS
October 13, 2026
Video
TRANSPIRE investigator Yasir Qazi, MD, explains how isolated MVI can signal kidney transplant injury before creatinine rises.
October 08, 2026
An AHA statement co-author says reproductive and family planning concerns belong in kidney care for women with glomerular disease.
October 06, 2026
Article
Nephrology in Q3 2026: FDA approvals for atacicept, iptacopan, finerenone, and obinutuzumab, plus 2-year IgAN data and CKD screening.
October 05, 2026
Nephrology in September 2026: FDA approves finerenone for CKD in T1D and obinutuzumab for nephrotic syndrome, plus ORIGIN 3 IgAN data.
September 29, 2026
Final ORIGIN 3 analysis shows a 76% lower risk of kidney disease progression vs placebo through 2 years.
September 25, 2026
An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.
In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss UACR screening for patients with CKD and T1D.
Pranav Garimella discusses what a potential USPSTF kidney screening recommendation could mean for high-risk adults and primary care.
September 24, 2026
As the USPSTF considers evidence for updated CKD screening guidance, Garimella discusses gaps in kidney disease detection and what the review should capture.
September 22, 2026
In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the FDA's recent approval of finerenone for CKD with T1D.
